期刊文献+

食管癌患者放疗前后血清TSGF检测的临床价值 被引量:4

Clinical Value of the Serum Levels of TSGF in Patients with Esophageal Carcinoma Around Radiotherapy
在线阅读 下载PDF
导出
摘要 目的:探讨血清肿瘤特异性生长因子(TSGF)含量检测在食管癌诊治中的临床价值。方法:采用透射比浊法检测94例食管癌患者和30例正常人血清TSGF含量,并对部分患者放疗前后的血清TSGF含量进行动态观察。结果:食管癌患者血清TSGF含量明显高于正常人(P<0.05);患者血清TSGF含量与临床分期无明显相关性;患者放疗后血清TSGF含量明显低于放疗前(P<0.05)。结论:血清TSGF含量检测在食管癌的诊断及疗效观察中具有一定的临床价值。 Objective:To evaluate the clinical value of the serum level of TSGF in diagnosis and treatment for patients with esophageal carcinoma.Methods:The serum levels of TSGF in 94 patients with esophageal carcinoma and 30 healthy subjects were detected by turbidimetry.The dynamic variation in the serum levels of TSGF in the pre-radiotherapy and post-radiotherapy were evaluated in part of patients.Results:The serum levels of TSGF in esophageal carcinoma patients were significantly higher than that in healthy subjects(P0.05).No significance in the serum levels of TSGF for patients in different clinical stages were found(P0.05).The serum levels of TSGF in post-radiotherapy patients significantly decreased as compared to that in pre-radiotherapy patients(P0.05).Conclusions:Detect ion of the serum level of TSGF is of significance in making diagnosis,determining outcome for esophageal carcinoma patients.
机构地区 中航工业
出处 《航空航天医学杂志》 2011年第5期537-538,541,共3页 Journal of Aerospace medicine
关键词 食管癌 放射治疗 肿瘤特异性生长因子 比浊法 Esophageal carcinoma radiotherapy Tumor specific growth factor(TSGF) Turbidimetry
  • 相关文献

参考文献8

二级参考文献37

  • 1黄雅珍.肿瘤特异性生长因子对肿瘤筛查意义[J].医学研究杂志,1999,33(9):26-27. 被引量:1
  • 2寇仁业,孙桂武,刘桂兰,王建军,袁著欣,李晓娣.食管癌患者血清唾液酸测定的临床价值[J].实用肿瘤学杂志,1993,7(3):61-62. 被引量:4
  • 3郭国平,周琴,华召来,李茂生,王建明.扬中市1991~2002年胃癌、食管癌发病趋势[J].中国肿瘤,2005,14(4):232-234. 被引量:13
  • 4武建国.血清肿瘤标志物检测中值得注意的问题[J].中华医学检验杂志,1997,20(1):7-8. 被引量:27
  • 5叶明.介绍一种癌症早期诊断方法[J].福建医学检验,1996,1(1):31-31.
  • 6Baccala AA, Zhong H, Clift SM, Nelson WG, Marshall FF,Passe TJ, Gambill NB, Simons JW. Serum Vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer.Urology 1998;51:327-332.
  • 7Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J. Prognostic value of Vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 2000; 83:775-781.
  • 8Brockmann JG, St Nottberg H, Glodny B, Sprakel B, Senninger N. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer. Anticancer Res 2000;20:4899-4904.
  • 9Mealy K, Feely J, Reid I, McSweeney J, Walsh T, Hennessy TP.Tumour marker detection in oesophageal carcinoma. Eur J Surx, Oncol 1996;22:505-507.
  • 10Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H,Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T,Kobayashi S, Ochiai T. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.Cancer 2000;89:1677-1683.

共引文献37

同被引文献37

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部